Suppression of hepatic hematopoiesis with radioactive gold (198Au).
A patient with idiopathic myelofibrosis of some 20 yr duration developed esophageal varices and ascites. No explanation for increased portal pressure other than hepatic hematopoiesis was found. Consequently, a trial of cobalt irradiation to the liver was undertaken with definite but transient decrease in ascites. Subsequently, two courses of radioactive colloidal gold were given, again with definite but transient beneficial effects on the degree of ascites. This latter benefit occurred without suppression of marrow function.
Turner
A R
AR
Gummerman
L W
LW
Boggs
D R
DR
D000368:Aged; D001201:Ascites / Q000209:etiology / Q000532:radiotherapy; D003131:Combined Modality Therapy; D004932:Esophageal and Gastric Varices / Q000209:etiology / Q000532:radiotherapy; D006048:Gold Colloid, Radioactive / Q000627:therapeutic use*; D006410:Hematopoiesis / Q000528:radiation effects*; D006801:Humans; D006975:Hypertension, Portal / Q000209:etiology / Q000532:radiotherapy; D008099:Liver / Q000528:radiation effects*; D008297:Male; D055728:Primary Myelofibrosis / Q000150:complications / Q000628:therapy; D013156:Splenectomy
D006048:Gold Colloid, Radioactive